SNDX - Syndax Pharmaceuticals Inc
IEX Last Trade
12.57
-0.100 -0.796%
Share volume: 28,766
Last Updated: Fri 27 Dec 2024 05:30:15 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.39%
PREVIOUS CLOSE
CHG
CHG%
$12.67
-0.10
-0.79%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | |
| Report Date | 2022-05-09 | 2022-08-08 | 2022-11-03 | |
| Total revenue | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | |||
| Operating expenses | 36.858 M | 37.724 M | 35.141 M | |
| Selling general and admin | 6.836 M | 7.990 M | 8.240 M | |
| Research and development | 30.022 M | 29.734 M | 26.901 M | |
| Total expenses | 36.858 M | 37.724 M | 35.141 M | |
| 2.35% | -6.85% | |||
| Operating income | -36.858 M | -37.724 M | -35.141 M | |
| Ebit | -36.858 M | -37.724 M | -35.141 M | |
| Pretax income | -37.169 M | -37.572 M | -35.403 M | |
| 1.08% | -5.77% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | -37.169 M | -37.572 M | -35.403 M | |
| -1.08% | 5.77% | |||
| Net income | -37.169 M | -37.572 M | -35.403 M | |
| -1.08% | 5.77% |